Global Community

Are the official reports and nubers even credible? I found are multiple stories in the German news (links below) about alleged insolvency and customers and stake holders not getting the money the company owes them - allergedly only when the court orders TPG to pay it's due.Read more

Every so often, a ticker flashes on my screen that makes me stop and rub my eyes. It is the kind of numbers that look like a mistake - like you thought you were getting clothes on Christmas Day when you were but a small boy, but then your parents surprise you by hiding the PlayStation 2 you've been wanting for months behind the living room chair.Read more

Teza inwestycyjna: Vistra to jeden z najlepiej ustawionych konkurencyjnych generatorów w USA na wzrost popytu na energię (szczególnie data centers + AI). Posiada solidną skalę, wartościowe aktywa nuklearne, zintegrowany model z retailem oraz atrakcyjniejszą wycenę niż najwyższej jakości peer (Constellation).Read more

Starfighters Space ( NYSE: FJET ) owns a fleet of supersonic F-104 aircraft (they call Starfighters) and plans to use them as a reusable first stage for space launches. This program, called STARLAUNCH, can lead to faster turnaround times for launch schedules and potentially lower costs than traditional methods.Read more

Dr. Sulaiman Al Habib Medical Services Group (Tadawul: 4013) Price: ~235 SAR | Market Cap: 82.0 Billion SAR | Enterprise Value (EV): 90.2 Billion SAR | Shares Outstanding: 350 Million Data as of early August 2026 close, post-Q2 2026 results. 01 — Insight: What is the market missing?Read more

Oriental Kopi teams up with a well-connected Indonesian retail group to open restaurants in Indonesia, starting in Jakarta, instead of going it alone. The deal aims to let the company grow faster while earning ongoing brand and support fees, but the payoff likely comes later as new locations ramp up.Read more

Figma is moving from a single design tool into a connected workspace where product, marketing, and web teams can create and publish without bouncing between apps. The big question is whether that “all-in-one” pull and new AI features keep it hard to replace as deep-pocketed rivals close the gap.Read more

UCB looks expensive against a cash‑flow based estimate and what similar drugmakers suggest, but the gap sits inside a wide range where small long‑term assumptions can swing the outcome. The big question is how much confidence you can place in far‑future growth and the drug pipeline when most of today’s “value” comes from years beyond the near term.Read more

A small silver explorer in Argentina starts with a known high-grade deposit and ready-to-use site infrastructure, then drills hard to prove the area is much bigger than the current find. Big-name backers add credibility, but the project still needs key technical studies and clarity on how cleanly the metal can be processed.Read more